Stay updated on FLT3 Inhibitor Combo in AML Clinical Trial
Sign up to get notified when there's something new on the FLT3 Inhibitor Combo in AML Clinical Trial page.

Latest updates to the FLT3 Inhibitor Combo in AML Clinical Trial page
- Check4 days agoChange DetectedThe page now displays the latest release tag Revision: v3.6.4, replacing the previous Revision: v3.6.3.SummaryDifference0.0%

- Check11 days agoChange DetectedNew sections Study Status and Study Identification were added to the record history, and a new version entry (106) from 2026-06-23 was introduced along with an update on 2026-07-14; the 2025-09-12 entry was removed.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe revision history now includes a new entry for Revision: v3.6.3 and the previous Revision: v3.6.0 is removed from the history, representing a minor metadata update to the record viewer.SummaryDifference0.0%

- Check46 days agoChange DetectedThe recruitment status was updated to 'No longer looking for participants,' indicating the study is not enrolling; the history now shows a new revision tag (v3.6.0) replacing the previous one (v3.5.5).SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision line on the history page was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a new version of the page template or data.SummaryDifference0.0%

- Check75 days agoChange DetectedA new revision entry appears: v3.5.4 replaces the previous v3.5.3 in the page history, reflecting an update to the revision metadata.SummaryDifference0.0%

Stay in the know with updates to FLT3 Inhibitor Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FLT3 Inhibitor Combo in AML Clinical Trial page.